Barclays, Guardant Health
We recently compiled a list of the 10 Firms Kick Off Trading Week Soaring. In this article, we are going to take a look at ...
In terms of valuation, Guardant Health Inc’s market capitalization stands at $6.00 billion. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market ...
Leerink Partners analyst Puneet Souda has maintained their bullish stance on GH stock, giving a Buy rating yesterday.Invest with Confidence: ...
Despite Guardant Health's positive Q4 2024 report, it remains unprofitable with negative cash flow, unlike its peer Natera.
Guardant Health Inc (GH) stock saw a modest uptick, ending the day at $45.13 which represents a slight increase of $8.47 or 23.10% from the prior close of $36.66. The stock opened at $39.04 and ...
Guardant Health, Inc. (NASDAQ:GH) announced that Palmetto GBA, a Medicare administrative contractor that administers the ...
Guardant Health stock hit a 13-month high Tuesday after Medicare officials agreed to pay for the company's colon cancer blood ...
In an early look at its annual earnings report, Guardant Health posted revenue gains of 31%—with the $737 million total ...
Guardant Health has not completed preparation of its financial statements for the fourth quarter or full year of 2024. The ...
Guardant Health, Inc. is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions ...
PALO ALTO, Calif. - Guardant Health , Inc. (NASDAQ: NASDAQ:GH), a precision oncology company with a market capitalization of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback